HIV Treatment Bulletin - Vol. 5, No. 7, August/September 2004
Simon Collins, HIV i-Base
HIV-positive people often belong to groups associated with high risk for hepatitis infection, and guidelines therefore recommend screening HIV patients for hepatitis A, B and C when diagnosed with HIV, and subsequent vaccination for hepatitis A and B when antibodies for either virus is not present.
However, the effectiveness of vaccinations is reduced even with relatively low reductions of CD4 levels. CD4 increases following HAART have previously been reported not to return to earlier response levels with all vaccines, so there is may be only a short window period to obtain protection for many HIV-positive individuals.
Several interesting poster presentations contributed to understanding determinants of vaccine response, and one study suggested that this could be safely increased by doubling the dose of vaccine used in HIV patients.
040810
IB040507-16
©2004. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.